P enile cancer is rare, representing less than 1% of all UK cancer diagnoses. It most commonly presents in the fifth decade and involves the glans or prepuce in over 80% of cases. 1 While squamous cell carcinoma (SCC) is the dominant pathology, other subtypes including basaloid, warty and adenosquamous also exist. 2 Human papillomavirus (HPV) and phimosis are the most important risk factors for the development of penile cancer.The prognosis is highly dependent on stage at diagnosis, ranging from 90% five-year survival with localised disease, to 40% with more than two lymph nodes involved. Due to the rarity of the disease, there is limited level 1 evidence for the management of penile cancer, and guidelines are often based on retrospective, single-centre studies.
EPIDEMIOLOGYAlthough penile cancer is rare, with approximately 620 cases diagnosed in the UK annually, the incidence is increasing. Over the last decade the incidence in the UK has increased by 25%, with the majority of cases diagnosed in those over 65 years. 3 The increased incidence is explained by changes in sexual practice (resulting in higher exposure to HPV), decreasing rates of circumcision and an ageing population. 4
RISK FACTORSA number of risk factors for penile cancer have been identified, including HPV infection, smoking, circumcision state, phimosis, poor hygiene and low socioeconomic status. 5 HPV infection, which is associated with an increased number of sexual partners, a history of genital warts and concomitant sexually transmitted diseases, is a strong risk factor for penile cancer. As many as 60-80% of penile cancers are associated with HPV infection, 5